Search - tctmd.com

Displaying 261 - 280 of 410

Sort: Relevancy | Date

Presentation TCT 2016

Case #4: ASD Closure in an Elderly Patient

Presenter: Ziyad M. Hijazi, Damien P. Kenny, Matthew A Crystal

October 30, 2016

Presentation TCT 2016

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Presenter: Horst Sievert

October 30, 2016

Presentation TCT 2016

PFO Closure: Rationale, Patient Selection and Outcomes

Presenter: Sarah Clarke, Megan M Kennison

October 30, 2016

Presentation SOLACI 2016

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

Presenter: Carlos AC Pedra

June 09, 2016

Presentation

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Presenter: David M. Kent

February 22, 2016

Presentation Scripps 2016

Can we identifiy the patient who will benefit from PFO closure?

Presenter: John D. Carroll

February 04, 2016

Presentation

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Presenter: Pablo Rengifo

October 29, 2015

Presentation TCT 2015

Creation of PFO/ASD in Patients With Pulmonary Hypertension: What Is the Correct Size?

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Clifford J. Kavinsky

October 15, 2015

Presentation TCT 2015

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Presenter: David W.M. Muller, John F. Rhodes, Zahid Amin

October 14, 2015

Presentation TCT 2015

Acroredis, Iris Fit, and CARAG ASD Occluder

Presenter: David W.M. Muller, John F. Rhodes, Horst Sievert

October 14, 2015

Presentation TCT 2015

GSO: Good-bye Helex

Presenter: David W.M. Muller, John F. Rhodes

October 14, 2015

Presentation TCT 2015

Congenital Heart Disease: PFO, ASD, VSD, and PDA

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 12, 2015

Presentation

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

Presenter: Paolo Scacciatella

July 07, 2015

Presentation

PFO Closure Following Cryptogenic Stroke or TIA

Presenter: Mikaeil Mirzaali

July 02, 2015

Presentation ECHO 2015

Imaging for Transcatheter Closure of ASD and VSD

Presenter: Robert J. Sommer

April 28, 2015

Presentation ARCH 2015

Structural Cases

Presenter: Alejandro Aquino

April 09, 2015

Presentation Cardiovascular Interventions 2014

PFO, PDA, VSD: Should All the Holes Be Closed?

Presenter: Matthew J. Price

October 24, 2014

Presentation

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

Presenter: Christopher A. Pickett

September 30, 2014

$PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura$

Presentation TCT 2014

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, David Hildick-Smith

September 16, 2014

Presentation TCT 2014

The Genetic Basis Of Patent Foramen Ovale

Presenter: Nabil Noureddin

September 16, 2014

Advertisement

Case #4: ASD Closure in an Elderly Patient

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

PFO Closure: Rationale, Patient Selection and Outcomes

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Can we identifiy the patient who will benefit from PFO closure?

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Creation of PFO/ASD in Patients With Pulmonary Hypertension: What Is the Correct Size?

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Acroredis, Iris Fit, and CARAG ASD Occluder

GSO: Good-bye Helex

Congenital Heart Disease: PFO, ASD, VSD, and PDA

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

PFO Closure Following Cryptogenic Stroke or TIA

Imaging for Transcatheter Closure of ASD and VSD

Structural Cases

PFO, PDA, VSD: Should All the Holes Be Closed?

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

The Genetic Basis Of Patent Foramen Ovale

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content